Human IgM monoclonal antibody to ganglioside GM2 and complement suppress virus propagation in ex vivo cultures of lymphocytes from HIV-1 infected patients

被引:7
|
作者
Okada, N
Wu, XS
Mizokami, M
Irie, RF
Okada, H
机构
[1] Nagoya City Univ, Sch Med, Dept Biol Mol, Nagoya, Aichi 4678601, Japan
[2] Nagoya City Univ, Sch Med, Dept Internal Med 2, Nagoya, Aichi 4678601, Japan
[3] John Wayne Canc Inst, Dept Biotechnol Sci, Santa Monica, CA 90404 USA
关键词
HIV; IgM; ex vivo; complement;
D O I
10.1111/j.1348-0421.1999.tb02462.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV-1 infection induces aberrant ganglioside GM2 expression on infected cell lines, and human IgM anti-GM2 monoclonal antibody (L55 Ab) together with normal fresh human serum (FHS) as a source of complement causes complement mediated cytolysis of HIV-1 infected cells as well as HIV-1 particles. We report here that high expression of GM2 was also detected on HIV-1 infected lymphocytes from HIV-1 seropositive patients. L55 Ab effectively suppressed the generation of HIV in the presence of FHS in primarily cultured lymphocytes from HIV-1 infected patients in ex vivo experiments, and the suppression was enhanced additively by AZT. These data suggest that L55 Ab may increase the therapeutic effect of chemotherapy.
引用
收藏
页码:723 / 727
页数:5
相关论文
共 50 条
  • [41] Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG
    Zahid, Hasan Md
    Kuwata, Takeo
    Takahama, Shokichi
    Kaku, Yu
    Biswas, Shashwata
    Matsumoto, Kaho
    Tamamura, Hirokazu
    Matsushita, Shuzo
    RETROVIROLOGY, 2021, 18 (01)
  • [42] A SYNTHETIC PROTEIN CORRESPONDING TO THE ENTIRE VPR GENE-PRODUCT FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS HIV-1 IS RECOGNIZED BY ANTIBODIES FROM HIV-INFECTED PATIENTS
    GRASMASSE, H
    AMEISEN, JC
    BOUTILLON, C
    GESQUIERE, JC
    VIAN, S
    NEYRINCK, JL
    DROBECQ, H
    CAPRON, A
    TARTAR, A
    INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1990, 36 (03): : 219 - 226
  • [43] EX-VIVO EXPANSION OF CD4 LYMPHOCYTES FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS IN THE PRESENCE OF COMBINATION ANTIRETROVIRAL AGENTS
    WILSON, CC
    WONG, JT
    GIRARD, DD
    MERRILL, DP
    DYNAN, M
    AN, DD
    KALAMS, SA
    JOHNSON, RP
    HIRSCH, MS
    DAQUILA, RT
    WALKER, BD
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01): : 88 - 96
  • [44] Detection of intestinal microsporidiosis in diarrhoeal patients infected with the human immunideficiency virus (HIV-1) using PCR and uvitex-2B stain
    Endeshaw, T
    Kebede, A
    Verweij, JJ
    Wolday, D
    Zewide, A
    Tsige, K
    Abraham, Y
    Messele, T
    Polderman, AM
    Petros, B
    ETHIOPIAN MEDICAL JOURNAL, 2005, 43 (02) : 97 - 101
  • [45] EXPRESSION OF A FUNCTIONAL P75 INTERLEUKIN-2 RECEPTOR ON LUNG LYMPHOCYTES FROM PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION
    ZAMBELLO, R
    TRENTIN, L
    BENETTI, R
    CIPRIANI, A
    CRIVELLARO, C
    CADROBBI, P
    AGOSTINI, C
    SEMENZATO, G
    JOURNAL OF CLINICAL IMMUNOLOGY, 1992, 12 (05) : 371 - 380
  • [46] COMPARISON OF ANTIBODY REACTIVITY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) GP160 EPITOPES IN SERA FROM HIV-1-INFECTED INDIVIDUALS FROM TANZANIA AND FROM THE UNITED-STATES
    WARREN, RQ
    NKYA, WMMM
    SHAO, JF
    ANDERSON, SA
    WOLF, H
    HENDRIX, CW
    KANDA, P
    WABUKE, M
    BOSWELL, RN
    REDFIELD, RR
    KENNEDY, RC
    JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (01) : 126 - 131
  • [47] Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter
    Demeter, LM
    Bosch, RJ
    Coombs, RW
    Fiscus, S
    Bremer, J
    Johnson, VA
    Erice, A
    Jackson, JB
    Spector, SA
    Squires, KM
    Fischl, MA
    Hughes, MD
    Hammer, SM
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) : 2089 - 2094
  • [48] Noncytolytic inhibition of X4 virus by bulk CD8+ cells from human immunodeficiency virus type 1 (HIV-1)-Infected persons and HIV-1-Specific cytotoxic T lymphocytes is not mediated by β-chemokines
    Geiben-Lynn, R
    Kursar, M
    Brown, NV
    Kerr, EL
    Luster, AD
    Walker, BD
    JOURNAL OF VIROLOGY, 2001, 75 (17) : 8306 - 8316
  • [49] REDUCED CAPACITY OF ANTIBODIES FROM PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) GROUP-O TO NEUTRALIZE PRIMARY ISOLATES OF HIV-1 GROUP-M VIRUSES
    NYAMBI, PN
    NKENGASONG, J
    PEETERS, M
    SIMON, F
    EBERLE, J
    JANSSENS, W
    FRANSEN, K
    WILLEMS, B
    VEREECKEN, K
    HEYNDRICKX, L
    PIOT, P
    VANDERGROEN, G
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (05): : 1228 - 1237
  • [50] Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1)
    Campos, Karoline Rodrigues
    Goncalves, Maria Gisele
    Costa, Nadia Aparecida
    Caterino-de-Araujo, Adele
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2017, 21 (03): : 297 - 305